Related by context. All words. (Click for frequent words.) 72 Improves Outcomes 69 Shows Promise Against 69 Soft Tissue Sarcoma 67 Predict Response 67 Reduces Mortality 66 Prolongs Survival 66 Node Positive 66 Adjuvant Chemotherapy 65 FDA Approves Drug 65 HER2 Positive 65 Slows Progression 65 Anthracycline 64 Squamous Cell 64 Ovarian Cancer Patients 64 Chemoradiation 64 Patients Treated With 64 Patients Receiving 64 Relapsed Refractory 64 Prednisone Against Refractory 64 Advanced Melanoma 64 Proves Effective 64 Hepatocellular 64 metastatic gastric 64 Bone Metastases 64 Exposure Linked 64 Spinal Fusion 63 Myelodysplastic Syndromes 63 HER2 Positive Breast Cancer 63 Accelerated Partial Breast Irradiation 63 Adjuvant Treatment 63 Advanced Prostate Cancer 63 Tyrosine Kinase Inhibitors 63 Test Detects 63 REMINDER ORLive Presents 63 Shows Efficacy 63 Successfully Treats 63 Appears Safe 63 Breast Cancer Recurrence 63 Treatment Reduces 63 Helps Detect 63 Chronic Renal Failure 63 Hormone Refractory Prostate Cancer 63 Previously Untreated 62 Improves Survival 62 Smoking Linked 62 ORLive Presents 62 Reduces Pain 62 Systemic Sclerosis 62 Estrogen Receptor 62 ® lenalidomide 62 Peginterferon alfa 2b 62 Hormone Receptor Positive 62 Vaccine Shows Promise 62 Secondary Hyperparathyroidism 62 See CLINICAL PHARMACOLOGY 62 Genes Predict 62 Unresectable 62 Breast Brachytherapy 62 Platinol ® 62 Non Invasive Treatment 62 metastatic pancreatic 62 Therapy Shows Promise 62 Genes Linked 62 Metastatic Pancreatic Cancer 62 lymphoma multiple myeloma 62 leukemia multiple myeloma 62 Lowers Risk 62 Patients Undergoing 62 Complicated Skin 62 External Beam 62 Castration Resistant Prostate Cancer 62 Prostatic 62 unresectable inoperable 62 Screenings Offered 62 Minimally Invasive Treatment 62 Cyclophosphamide 62 Slow Progression 61 Brain Atrophy 61 Drug Shows Promise 61 FDA Okays 61 Neuroendocrine Tumors 61 Therapy Improves 61 Metastatic Prostate Cancer 61 Kinase Inhibitors 61 Prolongs Life 61 Parathyroid 61 cisplatin gemcitabine 61 Allogeneic 61 Eases Pain 61 Renal Cell Cancer 61 recurrent epithelial ovarian 61 Breast Cancer Patients 61 Adenomas 61 Reduced Risk 61 Drug Prevents 61 T1c 61 essential thrombocythemia ET 61 systemic invasive fungal 61 Helps Diagnose 61 gastrointestinal stromal 61 Renal Cell Carcinoma 61 Basal Cell 61 Bladder Cancer 61 Acute myeloid leukemia 61 Coronary Arteries 61 untreated metastatic pancreatic 61 JAK2 Inhibitor 61 Antidepressants Linked 61 LHRH receptor positive 61 Antitumor Activity 61 metastatic malignant 61 R lenalidomide 61 Renal Artery 61 Nat Rev 61 Postmenopausal Osteoporosis 61 Endometrial Cancer 61 Contrast Agents 61 Renal Impairment 61 Leucovorin 61 Demonstrates Potential 61 Newly Diagnosed Multiple Myeloma 61 Cell Transplants 61 Adjuvant Therapy 61 Hsp# Inhibitor 60 Newly Diagnosed 60 Adjunctive Therapy 60 Cancer Patients Treated 60 Treatment Shows Promise 60 Demonstrates Sustained 60 NECK CANCER SUPPORT GROUP 60 Therapeutic Efficacy 60 Pancreatic Adenocarcinoma 60 Demonstrates Significant 60 novel emulsion formulation 60 Investigational Treatment 60 Subtypes 60 Newly Diagnosed Breast Cancer 60 Metastases 60 Long Term Efficacy 60 Androgen Deprivation Therapy 60 Diabetic Foot Ulcer 60 Levels Linked 60 Hepatitis C Genotype 60 papillary renal cell carcinoma 60 Temodar ® 60 Antitumor 60 myelodysplastic myeloproliferative diseases 60 Crohn colitis 60 Helps Identify 60 ovarian endometrial 60 Neoadjuvant 60 Myelodysplastic Syndrome 60 Colon Polyps 60 Maven Semantic 60 CT Angiography 60 Treating Chronic 60 Localized Prostate Cancer 60 Valvular 60 Gynecologic 60 Is Well Tolerated 60 Lymphoid 60 Recurrent Prostate Cancer 60 Tyrosine Kinase Inhibitor 60 5 fluorouracil leucovorin 60 Ovarian Cancers 60 Protein Linked 60 Spinal Disc 60 Peripheral Arterial 60 Bone Marrow Transplants 60 Initiates Clinical Trial 60 Severe Asthma 60 Improve Survival 60 Pancreas Cancer 60 HCV Protease Inhibitor 60 Guidelines Issued 60 Vulvar 60 completely resected 60 recurrent metastatic 60 resistant hormone refractory 60 TNF Blockers 60 Liver Metastases 60 Erythropoietic 60 Novel Therapeutic 60 included exfoliative dermatitis 60 Prostate Cancer Patients 60 Squamous Cell Carcinoma 60 Hematology Molecular Pathology 60 Arterial Disease 60 Prenatal Diagnosis 60 Effectively Treats 59 Previously Treated 59 Anticancer Drug 59 leukemia lymphoma multiple myeloma 59 Sentinel Lymph Node 59 Breast Cancer Treatment 59 Randomized Trials 59 Successfully Treated 59 Enlarged Prostate 59 Study Evaluating 59 Inhaled Corticosteroids 59 Patients Treated 59 deCODE ProstateCancer TM 59 Robot Assisted 59 Human Neural Stem 59 visit www.rtanswers.org 59 Fallopian Tube 59 Antigen Specific 59 Juvenile Idiopathic Arthritis 59 Combination REOLYSIN R 59 Stereotactic Radiosurgery 59 Ph + acute lymphoblastic 59 mild hepatic impairment 59 Chronic HCV 59 chronic rheumatic 59 Significantly Improves 59 Rheumatoid Arthritis Patients 59 Helps Predict 59 Teva Provides Update 59 transrectal ultrasound guided 59 RNAi Therapeutic 59 Transdermal Patch 59 Lumpectomy 59 Ventricular Arrhythmias 59 Intensity Modulated 59 Pharmacokinetics PK 59 radiation chemoradiation 59 Radical Prostatectomy 59 bladder ovarian 59 Prognostic Factors 59 Migraine Treatment 59 Regenerative Cell 59 Shows Statistically Significant 59 accumulate preferentially 59 Relapsing Multiple Sclerosis 59 acute myeloid 59 surgically resectable 59 Prospective Randomized 59 Mouse Model 59 Gynecological Cancers 59 metastatic colorectal 59 Esophageal 59 thalidomide Thalomid 59 Unstable Angina 59 Fludarabine 59 Gene Mutation Linked 59 Anticoagulants 59 cause mesothelioma asbestosis 59 Papillary 59 Receives Orphan Drug Designation 59 Pediatric Patients 59 endocrinology gastroenterology 59 Tissue Engineered 59 Demonstrates Efficacy 59 Renal Cancer 59 castration resistant hormone refractory 59 Malignant Glioma 59 Prostate Biopsy 59 metastatic bladder 59 CYT# potent vascular disrupting 59 lymphomas leukemias 59 Postmenopausal 59 advanced hepatocellular carcinoma 59 Gets FDA Clearance 59 unresectable Stage III 59 basal cell carcinoma squamous 59 Protease Inhibitor 59 non splenectomized 59 Vertebral Fractures 59 Desvenlafaxine Succinate 59 Proves Successful 59 Menopausal hormone therapy 59 interstitial brachytherapy 59 BRAF gene mutations 59 Disease Modifying 59 Leukemias 59 Elderly Patients 58 Cystic 58 Breast Reconstruction 58 Anti Tumor Activity 58 Preclinical Models 58 Causes Symptoms 58 Follicular Lymphoma 58 Improved Survival 58 Sentinel Lymph Node Biopsy 58 subependymal giant cell 58 ORAL HEAD AND 58 relapsed MM 58 Minimally Invasive Procedure 58 Nonsurgical 58 Adenocarcinoma 58 Initiate Clinical Trial 58 Brain Metastases 58 Treatment Naive Patients 58 gastric pancreatic 58 Hemodialysis Patients 58 endocrine refractory 58 unresectable tumors 58 Adenoma 58 Induction Therapy 58 Estrogen Therapy 58 leukopenia pancytopenia thrombocytopenia 58 Intravitreal 58 Post Operative 58 Imatinib mesylate 58 Proven Effective 58 related CMV Retinitis 58 demonstrated antitumor activity 58 deCODE BreastCancer 58 Heel Pain 58 Mitral Regurgitation 58 Metastatic Disease 58 Inhaled Nitric Oxide 58 Postmenopausal Women 58 Coronary Artery Bypass Graft 58 Prophylactic Treatment 58 undergoing radical cystectomy 58 Study Shows Benefits 58 Ablation System 58 Mouse Models 58 Shows Promising 58 Confirms Efficacy 58 Kinase Inhibitor 58 R Saizen R 58 Inflammatory Disease 58 Vitrasert R 58 Orally Active 58 Stress Urinary Incontinence 58 Malignant Melanoma 58 Thrombotic 58 Progressive Multifocal Leukoencephalopathy 58 Post Menopausal 58 Gastrointestinal Stromal Tumors 58 unresectable stage 58 Gastric Cancer 58 recurrent NSCLC 58 Announces FDA Clearance 58 G CSFs 58 Breast Tumor 58 Myeloma Patients 58 Lowers Blood Pressure 58 Lowers Cholesterol 58 leukemia lymphomas 58 Genes Involved 58 Trial Evaluating 58 NICE Recommends 58 Immunosuppressant 58 Novel Inhibitor 58 Demonstrate Significant 58 Lupus Nephritis 58 Dementia Diagnosis 58 Plaque Psoriasis 58 Postherpetic Neuralgia 58 Therapy Reduces 58 antimitotic 58 Knee Osteoarthritis 58 FUSILEV enhances 58 Muscle Wasting 58 Bosutinib 58 Hormonal Contraceptives 58 Treated Patients 58 Philadelphia Chromosome Positive 58 Lung Cancers 58 Launches Generic Version 58 Polymorphisms 58 Endometrial Ablation 58 Clinical Outcome 58 Could Detect 58 Combo Therapy 58 Tumor Response 58 Device Helps 58 Bioresorbable 58 Clinical Trial Evaluating 58 Immunotherapeutic 58 Intra Arterial 58 Axillary 58 Presents Preclinical Data 58 Levoleucovorin 58 Neurosurg 58 Acute Renal Failure 58 Heart Failure Patients 58 PLX STROKE targeting 58 Refractory Hodgkin Lymphoma 58 Nerve Stimulation 58 Small Bowel 58 Chronic Sinusitis 58 Phase 2b Clinical Trial 57 Breast Cancers 57 Psoriasis Drug 57 FDA Approvals 57 Factor Receptor 57 lung pancreatic 57 Breast Cancer Cells 57 Oral Fingolimod 57 Alimentary Tract 57 Shellgel TM injectable viscoelastic 57 Advanced Colorectal Cancer 57 Sleep Disturbances 57 ipsilateral breast 57 Renal Anemia 57 Stem Cell Transplants 57 Polymerase Inhibitor 57 Protease Inhibitors 57 treating sarcoma testicular 57 Single Dose 57 Lymph Node 57 Selective Internal 57 Hematological Malignancies 57 Completes Patient Enrollment 57 Resection 57 Radiation Treatment 57 Commonly Used 57 melanoma ovarian 57 deep venous thromboses 57 Fractionated 57 FDA Approves Generic 57 Stage IIIb 57 evaluating picoplatin 57 Oncolytic Reovirus 57 urethral bulking agent 57 Recommends Approval 57 Laryngeal Cancer 57 Brain Tumors 57 leiomyomas 57 Inflammatory Arthritis 57 Amgen Neulasta R 57 Osteoporosis Drugs 57 Arrhythmogenic 57 Demonstrates Positive 57 Pooled Analysis 57 Neurosurgical Products 57 Novel Treatments 57 Lung Cancer Survival 57 nonmetastatic 57 Hematopoietic 57 Skeletal Muscle 57 Temsirolimus 57 FDA Clears 57 Bayer HealthCare Onyx Pharmaceuticals 57 hormonally sensitive 57 Stem Cell Transplant 57 Renal Function 57 Angiographic 57 Receives Positive Opinion 57 Advanced Renal Cell 57 Trobalt 57 Colorectal Adenomas 57 Partial Nephrectomy 57 Pelvic Organ Prolapse 57 Osteoporosis Treatment 57 AMPLATZER R 57 Chronic Hepatitis C 57 Lung Tumors 57 Image Guided 57 stage IIIb IV 57 Submits NDA 57 Osteoporosis Screening 57 Phase IIa Clinical Trial 57 Gene Mutation 57 hypercholesterolemia liver 57 Oropharyngeal Candidiasis 57 Naive Patients 57 Autoimmune Diseases 57 Oncologic 57 advanced pancreatic neuroendocrine 57 Dose Escalation 57 kidney urologic 57 receiving chemoradiation therapy 57 Paediatr 57 Epidermal Growth Factor Receptor 57 5 lipoxygenase inhibitor 57 Neoadjuvant Chemotherapy 57 MR Angiography 57 Randomized Study 57 Ischemic 57 Iron Overload 57 Embolization 57 headache abdominal pain 57 IND Application 57 Metabolic Disease 57 Pre Cancerous 57 Ribavirin causes 57 Prostate Cancer Treatment 57 Combination Treatment 57 esophageal ulcers 57 Patients Suffering 57 refractory colorectal cancer 57 hypereosinophilic syndrome 57 Subarachnoid Hemorrhage 57 Acute myelogenous leukemia 57 benign prostatic hyperplasia enlarged 57 topically administered 57 Cutaneous T 57 chronic eosinophilic leukemia 57 INSPIRE Trial Phase III 57 Peritoneal Dialysis 57 Differential Diagnosis 57 Contrast Enhanced 57 Anti Tumor 57 Inflammatory Diseases 57 Bone Fractures 57 Parathyroid Hormone 57 Postmenopausal hormone therapy 57 Shows Promise 57 Endarterectomy 57 ovarian cervical 57 Metastatic Colorectal Cancer 57 Pericardial 57 asthma rheumatoid arthritis 57 Therapeutic Antibody 57 Clin J 57 Peginterferon Alfa 2a 57 Therapeutic Targets 57 severe oral mucositis 57 Combination Therapy 57 Dry Powder Inhalers 57 Kidney Function 57 Carotid Stenting 56 Endothelial Cells 56 Randomized Phase II 56 advanced HER2 positive 56 Atypical Hemolytic Uremic Syndrome 56 Recurrent Glioblastoma 56 Stem Cells Used 56 Completes Enrollment 56 myocardial infarction ventricular fibrillation 56 squamous cell carcinoma SCC 56 Contrast Agent 56 Files IND 56 Researchers Identify 56 Fracture Risk 56 Breast Tumors 56 Cardiovascular Disease Risk 56 Chronic Pelvic Pain 56 Artery Disease 56 dasatinib Sprycel ® 56 evaluate ZFP Therapeutic 56 Receives FDA Clearance 56 Relapsed Refractory Multiple Myeloma 56 Pulmonary Valve 56 Septic Shock 56 Drug Combo 56 incontinence erectile dysfunction 56 Xenografts 56 metastatic neuroendocrine tumors 56 Pharmaceuticals Initiates 56 receiving XGEVA 56 Lung Cancer Patients 56 stage IIIB 56 Respiratory Virus 56 Hypertriglyceridemia 56 severe hepatic insufficiency 56 Stent Graft System 56 Posaconazole 56 vaccine GMK 56 include ColorectAlert TM 56 melphalan prednisone 56 Glioblastoma Multiforme 56 Multiple Myeloma MM 56 Curon Control 56 alpha1 antitrypsin deficiency 56 treat musculoskeletal metabolic 56 Anticancer Activity 56 Sustained Efficacy 56 AVI BioPharma Announces 56 Irinotecan 56 Soft Tissue 56 Venous Thrombosis 56 please visit www.abraxane.com 56 Venous Thromboembolism 56 Chronic lymphocytic leukemia 56 Epoetin Alfa 56 Genital Warts 56 Needle Biopsy 56 candidates Azedra TM 56 Band 8a 56 Presents Positive 56 interstitial cystitis chronic 56 Initiates Enrollment 56 Nicotine Vaccine 56 Metastatic Renal Cell Carcinoma 56 papillary thyroid carcinoma 56 pain palliation 56 Roche Boniva 56 Clinical Efficacy 56 Fibromyalgia syndrome 56 Cardiac Rhythm 56 Cytarabine 56 abnormal pap tests 56 targeted antifolate 56 Antiangiogenic 56 Osteoporotic 56 Drug Candidate 56 Protein Synthesis 56 chemotherapy cisplatin 56 Spinal Fluid 56 Lifewatch 56 Decitabine 56 Antiviral Therapy 56 Previously Untreated Multiple Myeloma 56 Immunomodulatory 56 Study Demonstrates 56 anaplastic astrocytoma AA 56 Hypertrophy 56 Varicose Veins 56 3 registrational trial 56 humanised monoclonal antibody 56 Treating Prostate Cancer 56 Anthrax Toxin 56 Circulating Tumor Cells 56 Basal Cell Carcinoma 56 Cancer Treatments 56 Breast Carcinoma 56 Valvular Heart Disease 56 Being Studied 56 Kidney Transplant Patients 56 gemcitabine carboplatin 56 hormone refractory metastatic prostate 56 Cervical Dysplasia 56 DVT prophylaxis cholesterol 56 CIMZIA r certolizumab pegol 56 milnacipran HCl 56 Demonstrates Potent 56 Metastatic Melanoma 56 Dose Escalation Study 56 Breast Density 56 Contralateral 56 Stem Cell Treatment 56 Robotic Assisted 56 cisplatin chemotherapy 56 follicular Non Hodgkin 56 Myocardial Perfusion 56 Synaptic Plasticity 56 rheumatological 56 Advanced Solid Tumors 56 ST Elevation Myocardial 56 Assay Kits 56 IMiDs ® 56 Endocrinol 56 Chemotherapeutic 56 bladder prostate 56 Aggressive Prostate Cancer 56 anti PlGF 56 Aortic Valve 56 Hormone Replacement 56 Carotid 56 peritoneal carcinomatosis 56 Controlled Study 56 Ultrasound Guided 56 parathyroid carcinoma 56 Warfarin Coumadin 56 Immunomedics Announces 56 anaplastic astrocytoma 56 Anticonvulsant 56 Drug Resistant 56 Gastroesophageal Reflux Disease 56 cutaneous squamous cell carcinoma 56 mutated K ras 56 Cardiac Arrhythmia 56 Oral Calcitonin 56 Short Bowel Syndrome 56 Randomized Clinical Trials 56 Paraplatin ® 56 Meta Analysis 56 Capecitabine 56 Surgical Procedures 56 Meets Primary Endpoint 56 Uterine Fibroids 56 Lung Cancer Trial 56 Fibroblast 56 Tocopherol 56 Predict Prostate Cancer 56 colon rectal 56 Glucocorticoid 55 primary dysmenorrhea 55 Low Dose 55 Renal Insufficiency 55 Male Contraceptive 55 Phase 2b Trial 55 Uterine Fibroid Embolization 55 Present Preclinical Data 55 Pharmacologic 55 Metastatic Breast Cancer 55 Data Suggest 55 Microwave Ablation System 55 Targeted Therapy 55 Cytotoxic 55 Oral Presentations 55 Detrol Detrol LA 55 Successfully Completes Phase 55 Bleeding Disorder 55 Short Stature 55 Ectopic 55 syndrome overactive bladder 55 Teduglutide 55 Carcinoma 55 Phase Ib Clinical Trial 55 Intracerebral Hemorrhage 55 estrogen receptor beta agonist 55 Radiofrequency Ablation 55 Estrogen receptor positive 55 osteoarthritis osteoporosis 55 Aeolus Pharmaceuticals Announces 55 Further Validates 55 Microalbuminuria 55 Total Hip Arthroplasty 55 Predict Breast Cancer 55 Lung Injury 55 TNF Tumor Necrosis Factor 55 Critically Ill Patients 55 biliary tract cancer 55 Sinus Infections 55 urothelial cancer 55 Pancreatic Neuroendocrine Tumors 55 Mg Usa 55 lung esophageal 55 Aneurysm Repair 55 receptor tyrosine kinase inhibitor 55 Treatment Experienced 55 Allograft 55 Risk Stratification 55 Cyclooxygenase 2 55 Transcatheter 55 histologically confirmed 55 Drug Eluting 55 FIRMAGON 55 ovary uterus 55 metastatic androgen independent 55 Less Invasive 55 pT2 55 tuberous sclerosis TS 55 Systemic Therapy 55 underwent resection 55 radiotherapy RT 55 IMiDs ® compound 55 Eur J 55 somatostatin analog 55 Novel Compound 55 Novel Oral 55 Efficacy Trial 55 Advanced Ovarian Cancer 55 Reperfusion Injury 55 Left Ventricular Hypertrophy 55 Diagn 55 Scintigraphy 55 TM Everolimus Eluting 55 Treatment Approaches 55 Vidaza azacitidine 55 Magnetic Nanoparticles 55 Initiates Phase III 55 Malignancy 55 Blood Vessel 55 Myocardial Ischemia 55 Tumor Necrosis Factor 55 Treatment Resistant 55 Autoimmune Disease 55 convulsive disorders 55 Well Tolerated 55 Surgical resection 55 via intradermal injections 55 neoadjuvant treatment 55 Testosterone Therapy 55 metastatic medullary thyroid 55 Molecular Mechanism 55 Zorbtive TM 55 Progenitor Cells 55 Interferon beta 55 Vildagliptin 55 Peripheral Blood 55 aMCI precursor 55 Hepatobiliary 55 ovarian breast 55 Fludara ® 55 Cell Lymphoma 55 refractory metastatic 55 Monoclonal antibody 55 pulmonary hypertension PH 55 Acute Ischemic Stroke 55 Plaquenil 55 Atopic Dermatitis 55 Arteriovenous 55 Limb Ischemia 55 taxane chemotherapy administered 55 Antibiotic Resistant 55 Relapsed Multiple Myeloma 55 BCG refractory carcinoma 55 Dupuytren Disease 55 Immune Responses 55 Bone Grafting 55 Orthostatic Hypotension 55 Knee Arthritis 55 Magnetic Stimulation 55 clinicopathological features 55 Ablation 55 basal cell carcinoma BCC 55 Subgroup Analysis 55 Transdrug R 55 Total Knee Arthroplasty 55 demethylating agent 55 directed radiotherapeutic antibody 55 Dr. Assa Amit 55 CIMZIA R 55 chemoresistant 55 Taha Mohieddin Ma'rouf Vice 55 Cystoscopy 55 collagen vascular 55 Emerging Therapies 55 Observational Study 55 Receives Approvable Letter 55 Aurora Kinase 55 stage IIIA 55 Transdermal Delivery 55 AdnaTest 55 Alternative Treatments 55 Oral Cavity 55 Nail Fungus 55 Osteoporosis Drug 55 cholangiocarcinoma 55 mild renal insufficiency 55 Impairs 55 Vascular Grafts 55 pretreatment serum 55 bone marrow malignancy 55 Chronic Myeloid Leukemia 55 metastatic HER2 positive 55 Clinical Outcomes 55 Hemolysis 55 nonmelanoma 55 Being Evaluated 55 Unfractionated Heparin 55 Prostatectomy 55 #mg/#mg 55 Protease 55 intravesical infusion therapy 55 Cardiotoxicity 55 rotavirus shingles 55 Diabetic Neuropathy 55 Statin Therapy 55 Valve Replacement 55 achieved CCyR 55 CYP#A# substrate 55 SPRYCEL ® 55 Cell Proliferation 55 chemosensitizer 55 Menopausal Symptoms 55 Submits Biologics License Application 55 Mg Uk 55 Cardiovasc 55 cytidine nucleoside analog 55 Epilepsy Drugs 55 biologic DMARD 55 Bisphosphonate 55 pralatrexate injection folate analogue 55 treating sarcoma lymphoma 55 Holds Promise 55 Treating Heart Failure 54 Clot Busting 54 Benign Prostatic Hyperplasia 54 elderly myelodysplastic syndromes 54 Vocal Cord 54 Detection Evaluation 54 Recombinant Human 54 endometrial breast 54 corticosteroid induced 54 Clinical Trial Results 54 Stress Induced 54 Clinical Evaluation 54 Vaccine Adjuvant 54 Thrombus Aspiration 54 Bacterial Vaginosis 54 Mitomycin C 54 Acute Myeloid Leukaemia AML 54 interventional neuroradiologists 54 Beta Blocker 54 Neurol 54 Liver Tumors 54 pancreatic islet cell 54 Dehydrogenase 54 Screening Mammography 54 metastatic GIST 54 Immune Cell 54 Hematological 54 Heavy Menstrual Bleeding 54 Hormonal Therapy 54 endoscopic autofluorescence imaging 54 aggressive systemic mastocytosis 54 vinca alkaloid 54 Known hypersensitivity 54 NSABP B 54 aspirin clopidogrel 54 pancreatic colon 54 Anticoagulation 54 Bare Metal Stent 54 Intravenous immunoglobulin 54 Fluorouracil 54 Neuropathic 54 Disease Progression 54 Catheter Ablation 54 Carboplatin Paclitaxel 54 Attenuates 54 Smooth Muscle 54 underwent radical cystectomy 54 known sulfonamide allergy 54 GW# [003] 54 drug Treanda 54 BCG refractory 54 vapreotide acetate 54 Regimens 54 Blood Clots 54 Arthritis Sufferers 54 Ewings sarcoma 54 Randomized Controlled 54 Lung Cancer Drug 54 including cyclosporine methotrexate 54 aneurysms AAA 54 rhabdoid 54 androgen receptor antagonist 54 hyperlipidemia hypertension 54 nonbacterial prostatitis 54 Synthetic Peptide 54 Ultrasound Imaging 54 Acute Attacks 54 VALSTAR TM 54 diagnostic molecular imaging 54 CT Scanning 54 physicians podiatrists 54 intraepithelial neoplasia 54 Antipsychotic Drug 54 breast endometrial 54 ductal carcinomas 54 Growth Hormone Deficiency 54 Tumor Targeting 54 SPECIFICS Cotton Valley 54 Initiates Phase II 54 AnaSpec Introduces 54 Vascular Disrupting Agent 54 Coronary Angiography 54 Potentially Deadly 54 Cardiac Stem Cell 54 Drug Eluting Coronary Stent 54 Antisense Drug 54 Insulin Delivery 54 urologists gynecologists 54 administering VIVITROL 54 Tyrosine Kinase 54 lexidronam injection 54 Knee Prosthesis 54 elevated transaminases 54 radiofrequency ablation RFA 54 Hormone Therapy 54 Thiazolidinediones 54 pancreas esophagus 54 dyslipidemia hypertension diabetes 54 Chronic Heart Failure 54 Carcinomas 54 Torisel temsirolimus 54 Infected Patients 54 Autologous Stem Cell Transplantation 54 B Cell Malignancies 54 relapsed acute lymphoblastic 54 Hexvix ® 54 Lung Transplants 54 Osteomyelitis 54 Tigecycline 54 bladder carcinoma 54 Taclonex R 54 von Willebrand Disease 54 invasive lobular 54 alpha interferons 54 Carbamazepine 54 oral TLR7 agonist prodrug 54 curing muscular dystrophy 54 ovarian colon 54 Hematologic 54 Vitrectomy 54 Prostate Cancer Vaccine 54 hematological diseases 54 Pain Therapy 54 Diabetic Patients 54 Percutaneous Tibial Nerve Stimulation 54 CD# CD# 54 gefitinib Iressa 54 Acquired Cardiovascular Disease 54 Interferon Alpha 54 Resurgex Plus R 54 Malignancies 54 tumors GIST 54 Placebo Controlled Study 54 Brain Tumor Patients 54 Stromal 54 Cystectomy 54 Oral Spray 54 medic Naseer 54 Implantable Device 54 Silicone Breast Implants 54 refractory gastrointestinal stromal 54 pancreatic bladder 54 allogeneic hematopoietic cell 54 potent suppressor 54 Urinary Incontinence